Home Business 590 yuan a pill, sold out in 10 minutes after opening the...

590 yuan a pill, sold out in 10 minutes after opening the door! Who is hyping “Moutai in medicine”?

0

China-Singapore Jingwei Client, June 21 (Lin Wansi Gaojia) Pien Tze Huang has always been called “Moutai in Medicine”. Recently, some consumers have reported that buying Pien Tze Huang is the same as buying Moutai. You need to queue up in advance and limit the purchase to 2 tablets per person for online purchases. Online purchases also need to work hard to see luck. what on earth is it?

Pien Tze Huang Experience Hall offline store.Photo by Lin Wansi, China-Singapore Jingwei
Exploring the offline store in Pien Tze Huang: “Limited purchase” of 2 tablets per person, sold out within 10 minutes after opening the door
On the morning of the 21st, the Sino-Singapore Jingwei client came to the Pien Tze Huang Experience Hall Beijing Galaxy SOHO store. There was still a quarter of an hour before the opening time of 9 o’clock, and several people had queued at the door.
At this time, the Pien Tze Huang clerk asked customers who lined up outside the store to scan the code to fill in information such as ID card, residential address, and mobile phone number, and said that only one person can enter the store at a time to make a purchase. Seeing that the line at the door was getting longer and longer, the clerk began to “persuade me to retire”: “Today, two pills are issued, and they only sell to the 10th place.”
The Sino-Singapore Jingwei client observed that Pien Tze Huang was sold out 10 minutes after the door was opened, and the customers in the back had to return empty-handed.
It is understood that the current offline store price of Pien Tze Huang is 590 yuan per tablet. Although the above-mentioned stores do not need to make an appointment to purchase, customers who purchase 2 capsules on the same day will have the opportunity to buy again after 5 days, and those who purchase 1 capsule can only buy again after 3 days.
A customer asked where to buy 10 gift boxes as a gift. The clerk responded, “Now there are no products everywhere, it depends on your ability to buy it.” Some customers told the Sino-Singapore Jingwei client that their friends can only get one tablet within two weeks if they rely on internal channels.
In addition to offline “purchase restrictions”, on e-commerce platforms, Pien Tze Huang for 590 yuan is also hard to find. Many merchants sell Pien Tze Huang at a price ranging from 900 yuan to 1,600 yuan, the highest being the store price. More than 2 times more expensive. In addition, on social media such as Weibo, some netizens reported that the local Pien Tze Huang was fired at a price ranging from 900 yuan to 3,000 yuan.
Pien Tze Huang’s flagship store on Tmall “Pien Tze Huang Pharmacy Flagship Store” previously sold Pien Tze Huang, but the product’s webpage currently shows that it is “off shelves”. The 3-boxes, 5-boxes, 10-boxes, and 20-boxes in some online stores have been shown to be out of stock. You can only purchase the standard pack, that is, 1 pack. An online shop customer service told the Sino-Singapore Jingwei client that recently Pien Tze Huang manufacturers have restricted shipments, and they are also out of stock.

Screenshot source: e-commerce platform Who is hyping Pien Tze Huang? On the 21st, the Sino-Singapore Jingwei client contacted the sales department of the Pien Tze Huang headquarters, and the relevant person in charge responded that there was no purchase restriction policy. When receiving a telephone consultation from the Sino-Singapore Jingwei client, the clerk at the Pien Tze Huang Experience Hall Beijing Galaxy SOHO store also denied the existence of a purchase restriction policy. He claimed that the store will have goods every day, but because there are many buyers and few goods arrive, so early No more. The client of Sino-Singapore Jingwei called the Pien Tze Huang Experience Hall at Cha Ting Store in Fuzhou City, Fujian Province on the same problem. Regarding the phenomenon of “difficult to find a drug” in the current market, the clerk replied, “In fact, it is not that we restrict purchases, but that there are A lot of speculation has led to high premiums. In addition, the supply of goods is relatively tight, so there is a situation where medicines cannot be bought at high prices. In order to ensure that real consumers have medicines available, we have made this move and set up prescriptions in stores. The rule of buying one tablet with an ID card has become what everyone calls the “purchase restriction”.” “A pill shouldn’t be enough for consumers, right?” The clerk said to this question, “You can buy it after you eat it. For real consumers, we can guarantee that there are medicines. I am afraid that there will be a lot of speculation. People buy the medicines so that the people who use them have no medicines available.” As for whether there will be a price increase in the near future, the clerk replied that “the price will not increase”. The outer packaging of Pien Tze Huang shows that the ingredients of Pien Tze Huang are bezoar, musk, panax notoginseng and snake gall. According to the dosage of 0.6g per adult, it can be taken 5 times, 2 to 3 times a day. Based on this calculation, the cost of each consumption is about 100 yuan. Although Pien Tze Huang has always been called Maotai in medicine, the unit price of Pien Tze Huang is even lower than that of Maotai: the original price of 1499 yuan of 53 degrees Feitian Maotai 500ML, an average of about 3 yuan per milliliter, and Pien Tze Huang a 3g, you can sell it for 590 Yuan, about 197 yuan per gram on average. It is understood that Pien Tze Huang functions mainly to clear away heat and toxins, cool blood to remove blood stasis, reduce swelling and relieve pain, and is used for acute and chronic viral hepatitis caused by heat toxin and blood stasis, carbuncle boils, unknown swelling toxin, bruises and various inflammations. An industry insider told the Sino-Singapore Jingwei client that at present, the supply of raw materials such as bezoar and musk used in Pien Tze Huang is relatively sufficient. Other pharmaceutical companies may not be able to maintain sufficient supply, but Pien Tze Huang’s raw materials are not a big problem. According to the research report of Southwest Securities on February 7, 2021, Pien Tze Huang is currently promoting artificial musk breeding to make up for the shortage of scarce raw materials. The Shaanxi breeding base raises more than 10,000 musk musk. It is estimated that the annual output exceeds 100 kg. Both musk and bezoar can meet the three-year supply. Capacity expansion. The above-mentioned market participants also believe that there is hype, “Exclusive products are particularly prone to monopolize. Pien Tze Huang is not capable of being produced by any company, and the stock is limited, which can easily lead to malicious hype.” Liu Chunsheng, an associate professor at the Central University of Finance and Economics, told the Sino-Singapore Jingwei client that the price of Pien Tze Huang is rising steadily because on the one hand, the cost of certain raw materials is indeed more expensive, such as musk, which alone accounts for 55% of the total cost. . On the other hand, Pien Tze Huang has a state-level top-secret formula, which is very important in the Chinese medicine industry. Liu Chunsheng mentioned that with the consumption upgrade of the healthcare industry, Pien Tze Huang, 590 yuan a pill, actually acts as a “luxury” in medicine, in line with the current concept of consumption upgrades and emphasis on health. “At the same time, it is undeniable that, of course, there is also a factor of speculation. When Pien Tze Huang is in short supply and has the same financial attributes of investment as Moutai, the more speculation will be, the higher the speculation, the more difficult to find investment.’ The herding effect’.” Behind “One drug is hard to find”: Pien Tze Huang’s share price quadruples in 18 months Pien Tze Huang’s “it is hard to find a medicine” has also opened up the imagination of the capital market. At the beginning of 2020, the stock price of Pien Tze Huang was still in the early 100 yuan. On June 11 this year, its stock price broke through the historical high to reach 419.96 yuan per share. In just 18 months, the stock price has quadrupled and the market value has increased from more than 60 billion yuan. Yuan has soared all the way, and together with Yunnan Baiyao, they have become the only two Chinese medicine listed companies with a level of 100 billion. As of the close on June 21, Pien Tze Huang’s stock price was reported at 404.23 yuan per share, with a market value of 243.9 billion yuan, far surpassing Yunnan Baiyao’s 136 billion yuan in market value, and was firmly in the position of “the first brother of traditional Chinese medicine.” In addition, Pien Tze Huang’s 2020 financial report data shows that Pien Tze Huang achieved revenue of 6.511 billion yuan, an increase of 13.78% year-on-year; net profit of 1.672 billion yuan, an increase of 21.62% year-on-year. Among them, from the first quarter to the fourth quarter of 2020, Pien Tze Huang’s gross profit margin was 47.98%, 44.44%, 49.20%, and 37.45%, respectively. Pien Tze Huang said that the main reason is that the sales proportion of the pharmaceutical manufacturing industry has decreased, which makes the gross profit margin of sales. Compared with the previous three quarters, there has been a decrease. It is worth mentioning that although Pien Tze Huang’s performance has risen in 2020, the growth rate has slowed down significantly. From the financial report data in recent years, Pien Tze Huang’s revenue growth rate in 2017 was the fastest, reaching 60.85%, but then the revenue growth rate began to decline year by year, and it fell to the lowest point in the past five years by 2020, only 13.78% . According to Wind data, Pien Tze Huang was restructured and founded by the former Zhangzhou Pharmaceutical Factory in December 1999. It is a time-honored Chinese enterprise. Its main business includes the manufacture of Chinese patent medicines and the circulation of medicines. It was listed on the Shanghai Main Board in 2003. Among them, the core product is the Pien Tze Huang series, including Pien Tze Huang, Pien Tze Huang capsules, compound Pien Tze Huang lozenges and other Pien Tze Huang series products. (Zhongxin Jingwei APP) (The opinions in the article are for reference only and do not constitute investment advice. Investment is risky and you need to be cautious when entering the market.) All rights reserved by Sino-Singapore Jingwei. Without written authorization, no unit or individual may reprint, extract or use it in other ways. For more exciting content, please follow the official WeChat account of jwview

NO COMMENTS